- Report
- February 2026
- 150 Pages
Global
From €4427EUR$4,850USD£3,793GBP
- Report
- November 2025
- 150 Pages
Global
From €4427EUR$4,850USD£3,793GBP
- Report
- February 2026
- 200 Pages
United States
From €2729EUR$2,990USD£2,339GBP
- Report
- May 2023
- 187 Pages
Global
From €4771EUR$5,410USD£3,950GBP
- Report
- September 2021
- 354 Pages
Global
From €3099EUR$3,396USD£2,656GBP
€3646EUR$3,995USD£3,125GBP
- Report
- April 2024
- 75 Pages
Global
From €4244EUR$4,650USD£3,637GBP
- Report
- November 2024
- 100 Pages
Global
From €5431EUR$5,950USD£4,654GBP
- Report
- August 2025
- 200 Pages
Global
From €2273EUR$2,490USD£1,947GBP
- Report
- June 2025
Global
From €4472EUR$4,900USD£3,832GBP
- Report
- August 2023
- 145 Pages
Global
From €2875EUR$3,150USD£2,464GBP
- Report
- December 2024
- 205 Pages
Global
From €2282EUR$2,500USD£1,955GBP
- Report
- June 2025
- 400 Pages
Global
From €4517EUR$4,949USD£3,871GBP
- Report
- July 2024
- 200 Pages
Global
From €4517EUR$4,949USD£3,871GBP
- Report
- April 2023
- 147 Pages
Global
From €4517EUR$4,949USD£3,871GBP
- Report
- May 2024
- 167 Pages
Global
From €2282EUR$2,500USD£1,955GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4518EUR$4,950USD£3,871GBP
- Report
- July 2024
- 125 Pages
Global
From €4335EUR$4,750USD£3,715GBP
- Report
- April 2023
- 160 Pages
Global
From €4517EUR$4,949USD£3,871GBP
- Report
- March 2024
- 81 Pages
Global
€4559EUR$4,995USD£3,907GBP
- Report
- January 2024
- 258 Pages
Global
€4559EUR$4,995USD£3,907GBP

Rhinitis is a condition of the nose characterized by inflammation of the nasal mucosa, leading to symptoms such as sneezing, nasal congestion, runny nose, and itching. It is a common condition in the field of Allergy and Immunology, and can be caused by allergens, irritants, or infections. Allergic rhinitis is the most common type of rhinitis, and is caused by an allergic reaction to environmental allergens such as pollen, dust mites, and pet dander. Non-allergic rhinitis is caused by irritants such as smoke, strong odors, and weather changes. Treatment for rhinitis typically includes avoidance of triggers, medications, and immunotherapy.
Companies in the Rhinitis market include Sanofi, GlaxoSmithKline, Merck, Novartis, and Teva Pharmaceuticals. Show Less Read more